Search for: "Kat"
Results 6061 - 6080
of 6,603
Sorted by Relevance
|
Sort by Date
2 Mar 2015, 2:43 pm
.* A test-drive for the Unified Patent Court: Part III Here Jeremy hosts the third in the series of posts from London-based law firm Bristows (where guest Kat Tom works) on its real-time experiment in litigating before the proposed Unified Patent Court (UPC). [read post]
10 Mar 2020, 2:50 am
The anti-suit injunction would thus have effectively amounted to a deprivation of IPCom's property [par. 58].To this Kat, the reasoning of the appeal court holds more appeal (no pun intended). [read post]
12 Feb 2018, 7:59 am
Kat Murti will moderate. [read post]
14 Jul 2016, 10:09 am
For those who were unable to make it to Bishop's Square, some Kat friends who had less distance to travel - in the form of Elettra Bietti and Taly Dvorkis (both of A&O) - report on the event:"In light of the recent UK referendum vote to leave the EU and the potential impact on the Unified Patent Court, there is perhaps a potential increase in alternative dispute resolution (ADR) in the standard essential patents context. [read post]
9 Mar 2015, 8:00 pm
The fact that the BOA has accepted Pinterest’s supplemented evidence concerning its user figures in the context of showing goodwill at appeal stage will come as welcome news to internet based businesses, where success can often come fast and almost unexpected and before all IP is properly in place.For the sake of transparency, Pinterest was represented by Baker & McKenzie in the appeal where this Kat used to work when the appeal was filed. [read post]
18 Sep 2018, 5:47 am
Kat on fire! [read post]
31 Jan 2023, 10:19 am
In the consequentials hearing judgment [2023] EWHC 138 , the Judge dealt with (1) royalty payments; (2) costs; (3) confidentiality; and (4) permission to appeal.Of the most interesting to this Kat was the treatment of costs (well, some of them), confidentiality and permission to appeal. [read post]
10 Jul 2013, 2:40 am
This Kat would like to express his deep gratitude to these three authors who, quite possibly during normal working hours and no doubt at risk to life and limb, took the time and trouble to write the following verses. [read post]
20 Nov 2020, 9:00 am
On this Kat's night stand during the long, locked-down nights in Florence was Amaka Vanni's monograph Patent Games in the Global South: Pharmaceutical Patent Law-Making in Brazil, India and Nigeria (Hart 2020). [read post]
22 Apr 2020, 2:51 am
COVID-19 is the topic of the days (or of the months to be more accurate), and this Kat is more than happy to post the Guest post by IPKat friends Gian Paolo Di Santo, Avv. [read post]
13 Jul 2015, 3:51 am
Former guest kat and current katfriend Rebecca Gulbul provides this brief but fascinating insight into Victoria Beckham's IP activities.Letter from AmeriKat: Hospira's Angiomax win, Apple jury award vacated & Obama's Pacific trade dealIn this late Sunday update, Annsley writes about the Court of Appeals for the Federal Circuit decision that Hospira’s generic version of The Medicines Company's anticlotting drug bivalirudin was not infringing, as… [read post]
20 Oct 2019, 1:59 am
Kats (with celebrities)(source: Zimbio)Conclusion This post has focused on preliminary copyright issues, notably the question of originality and authorship/joint authorship of celebrity paparazzi photographs (issues like licensing and copyright exceptions and limitations have been left out of the analysis). [read post]
20 Nov 2014, 9:58 am
Although there's still a long way to go, then, not all seems lost for the IPKat's couple of friends.A list of kat-posts mentioning the Bodurs here.The Bodurs' Facebook page here.The Bodurs' shop before and after this lawsuit. [read post]
5 Jan 2023, 12:40 am
After all, the one at issue in the present case is an advertisement – and advertising is one of the types of uses specifically indicated by law as being potentially infringing.According to the Supreme Court, thus, the key issue is not really whether the use of a sign is done in the course of trade, but rather whether it is use thereof as a trade mark.And here comes the interesting bit: according to the court, it is erroneous to think that a trade mark – especially a well-known one - is… [read post]
Bowman v Monsanto: the US Supreme Court rules on patent exhaustion and replication of patented seeds
14 May 2013, 2:09 pm
Yesterday, the Supreme Court of the United States delivered its long-awaited judgment in the case of Bowman v Monsanto Co. et Al., unanimously ruling that 'patent exhaustion does not permit a farmer to reproduce patented seeds through planting and harvesting without the patent holder's permission'. [read post]
14 Nov 2018, 3:25 am
Whilst we digest the decision in full, this Kat provides some context to some of key issues of the case.Preceding ProceedingsToday's Supreme Court case is the latest installment in a long-running dispute between Pfizer (parent company of Warner-Lambert) and Actavis et al. [read post]
2 May 2019, 11:10 am
The audience was very engaged with this topic, perhaps also because of its international implications.Over to guest Kat, Alexander de Leeuw (Brinkhof)for the report on the patent priority session:“Jennifer Jones (Bird & Bird), who moderated this session, explained that priority claims are treated differently across different patent systems throughout the world based on various policy arguments. [read post]
6 Feb 2013, 2:49 pm
This Kat's favourite music for meditation here. [read post]
26 Nov 2020, 2:56 am
Variety of Kats ... variety of website blocking ordersIt is thus apparent that the protection offered by this provision is wide-ranging: not only does it encompass the manufacture and distribution of devices, but it does also include, among other things, the advertising thereof and the provision of services (i.e. modding services).The CJEU has also clarified that the legal protection referred to in Article 6 is broad. [read post]
23 May 2022, 5:13 am
In the face of a clear disagreement within the Boards of Appeal, and the obvious discontent from many EPO users, this Kat continues to be bemused as to why the EPO remains so wedded to the onerous description amendment requirements introduced in the 2021 Guidelines. [read post]
